MAVUPHARMA
Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
MAVUPHARMA
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Kirkland, Washington, United States
Country:
United States
Website Url:
http://www.mavupharma.com
Total Employee:
1+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
SPF Font Awesome Apache Microsoft Exchange Online Office 365 Mail Linode
Current Advisors List
Current Employees Featured
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Mavupharma
Alpine BioVentures
Alpine BioVentures investment in Series A - Mavupharma
More informations about "Mavupharma"
Mavupharma - Crunchbase Company Profile & Funding
Organization. Mavupharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Non-nucleotide, conditional modulators of the …See details»
MAVUPHARMA Canadian Trademark Information
MAVUPHARMA is a canadian trademark and brand of Mavupharma, Inc., 5400 Carillon Point, Kirkland, WA 98033,UNITED STATES. This trademark was filed to the Canadian Intellectual …See details»
MAVUPHARMA, INC. Employer Identification Number EIN
Information about MAVUPHARMA, INC.'s IRS EIN. Employer Identification Number 81-3574603 MAVUPHARMA, INC. is a USA domiciled entity or foreign entity operating in the USA. ...See details»
Mavupharma, Inc. - Company Profile - Corporation Wiki
Mavupharma, Inc. Overview. Mavupharma, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Monday, March 20, 2017 and is approximately seven …See details»
MAVUPHARMA, INC. in Spokane, WA | Company Info & Reviews
Feb 25, 2024 MAVUPHARMA, INC. is a Washington Foreign Profit Corporation filed on September 1, 2016. The company's filing status is listed as Active and its File Number is …See details»
MAVUPHARMA, INC. Overview | SignalHire Company Profile
MAVUPHARMA, INC. is a private company that has been in the industry for 6 years. The company currently specializes in the Health Care Technology area ... Organization Website: …See details»
Mavupharma | VentureRadar
Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. Bio tech-Careers Associated sectors: Cancer Therapeutics; …See details»
Mavupharma, Inc. - CA, DE, IL, and WA - Bizapedia
MAVUPHARMA, INC. WASHINGTON FOREIGN PROFIT CORPORATION: WRITE REVIEW: Address: 1 N Waukegan Rd North Chicago, IL 60064-1802: Registered Agent: Corporate …See details»
MAVUPHARMA, INC. - Address, Director information
Corporation Name: MAVUPHARMA, INC. Incorporation Date: 3/20/2017 Jurisdiction: DE Corporation Status: ACTIVE Company Type: FOREIGN STOCK Address: 1 N WAUKEGAN …See details»
Mavupharma, Inc. (Mavupharma, Inc.) - 药物管线_专利_临床试验_ …
了解Mavupharma, Inc. (Mavupharma, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1篇新闻。 ... as we transition from a clinical-stage company into a commercial organization,” …See details»
Mavupharma Company Profile 2025: Valuation, …
Mavupharma General Information Description. Developer of non-nucleotide modulators designed to treat cancer and infectious disease. The company's modulators uses small molecules to indirectly and conditionally modulate the …See details»
Mavupharma - Company Profile - Tracxn
Nov 25, 2024 Mavupharma. has raised a total funding of $20M over 1 round. What are the most recent funding rounds of Mavupharma? Its latest funding round was a Series A round on Nov …See details»
Alpine Bioventures - teaserclub.com
As of July 2019, Mavupharma operates as a subsidiary of AbbVie Inc., benefiting from the larger organization's resources and expertise in the pharmaceutical industry. Alpine Immune …See details»
Mavupharma, Inc.:Company Profile & Technical Research ... - Patsnap
Mavupharma, Inc. is a company that provides Clinical research, Biology, Drug discovery and more. Mavupharma, Inc. is headquartered in United States Washington. Mavupharma, Inc. …See details»
Mavupharma - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 29, 2017: Series A - …See details»
Mavupharma - Tech Stack, Apps, Patents & Trademarks
The intellectual property of Mavupharma includes 5 registered patents primarily in the ' Organic Chemistry ' category, according to IPqwery. Additionally, Mavupharma has registered 2 …See details»
生物制药巨头艾伯维宣布收购Mavupharma，研发抗癌免疫药物
Jul 23, 2019 Mavupharma的平台将助力艾伯维开发抗癌药物。” Mavupharma联合创始人Michael Gallatin博士表示：“艾伯维在肿瘤学领域建处于领导地位，他们的先进技术将帮 …See details»
进军STING信号通路领域！艾伯维收购Mavupharma，扩充免疫肿 …
Jul 16, 2019 Mavupharma公司的先导临床候选疗法是MAVU-104，这是一种首创的（first-in-class）、具有口服活性的小分子ENP1抑制剂，ENP1是一种参与调控STING信号通路的酶。See details»
AbbVie收购Mavupharma，以抓住肿瘤免疫新靶点STING的机遇
AbbVie正在收购西雅图初创公司Mavupharma以获得其STING激动剂的所有权，将STING激动剂推向临床试验，并与检查点抑制剂进行联合，如PD-1 / PD-L1拮抗剂，希望可以消除对恶性肿瘤 …See details»
Research programme: small-molecule therapeutics - Mavupharma
Mavupharma (a subsidiary of AbbVie) is developing small molecule, orally bioavailable, non-nucleotide, conditional modulators of the STING (stimulator of ... If your organization has a …See details»